Journal of oral and maxillofacial pathology : JOMFP
Journal of oral and maxillofacial pathology : JOMFP
Audio Summaries
Every issue of Journal of oral and maxillofacial pathology : JOMFP moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Journal of oral and maxillofacial pathology : JOMFP.
Patient education using 3D animation and graphic medicine-Explained through dental caries model.
Nov 18, 2026
This paper addresses whether 3D animation and graphic medicine (comics) can make the histopathological sequence of dental caries, including demineralization of inorganic content and dissolution of organic material leading to cavity formation, easier for patients to understand. The authors created a 3D animation video and a comic using a dental caries model as educational tools. The abstract describes the design of these materials but does not report any evaluation of patient comprehension.
Expression of endoglin (CD105) and its correlation with mast cells across different grades of oral epithelial dysplasia and oral squamous cell carcinoma: A retrospective comparative study.
Nov 18, 2026
This retrospective study asked whether angiogenesis (measured by endoglin/CD105-based microvessel density) and mast cell density change across grades of oral epithelial dysplasia and oral squamous cell carcinoma, with pyogenic granuloma as a control. The authors found that endoglin-positive microvessel density rose progressively from dysplasia to carcinoma, peaking in poorly differentiated OSCC, while mast cell density increased in dysplasia but varied inconsistently in carcinoma. They conclude that angiogenesis increases significantly with disease progression and that mast cells may modulate early angiogenesis, though their role in advanced malignancy remains unclear.
Mitotic and apoptotic indices in oral epithelial dysplasia and oral squamous cell carcinoma: A systematic review.
Nov 18, 2026
This systematic review asked whether the mitotic index (MI) and apoptotic index (AI) can serve as tissue-based markers of progression from oral epithelial dysplasia to oral squamous cell carcinoma. Across 19 included studies, direct morphological evidence generally showed MI rising from normal mucosa through dysplasia to carcinoma, whereas AI patterns were less consistent. The authors conclude that MI may be a useful adjunct indicator of proliferative activity, but the evidence is of low to very low certainty, so standardized prospective studies are needed before routine clinical use.
Correlation of CD163-positive tumour-associated macrophages and β-catenin expression with histological grading in oral squamous cell carcinoma.
Nov 18, 2026
This study examined whether CD163-positive tumour-associated macrophage (M2-type) density and β-catenin expression vary with histological grade in oral squamous cell carcinoma (OSCC) and how the two relate. In 30 OSCC cases, CD163+ TAMs were highest in poorly differentiated tumours, while β-catenin expression declined with higher grade and nodal involvement, with a negative correlation between the two in moderately and poorly differentiated tumours. The authors conclude that CD163+ TAMs and reduced β-catenin may serve as markers of OSCC aggressiveness, though the small sample size limits how strongly this can be generalized.
Immunohistochemical evaluation of human epidermal growth factor receptor 2 expression in salivary gland malignancies.
Nov 18, 2026
This study used immunohistochemistry to examine HER2 expression in 20 malignant salivary gland carcinomas compared with 20 normal salivary gland samples, asking whether HER2 is present in these rare tumors and could inform targeted therapy. HER2 was absent in all normal tissues, while only 3 of 20 carcinomas showed weak (1+) staining, found in adenoid cystic carcinoma (40%) and polymorphous adenocarcinoma (20%), with no significant difference among subtypes (P = 0.365). The authors conclude that HER2 expression is limited, though potentially relevant for HER2-targeted therapy in select salivary gland cancer subtypes.
Clinical image-based artificial intelligence models for early detection and classification of oral cancer: A systematic review and meta-analysis.
Nov 18, 2026
This systematic review and meta-analysis asks how accurately image-based AI models, particularly CNN-based deep learning, can detect and classify oral squamous cell carcinoma and oral potentially malignant disorders from clinical photographs. Across 10 eligible studies (over 47,000 clinical images), the pooled sensitivity was 0.86, specificity was 0.92, and diagnostic odds ratio was 87.43, with no statistically significant publication bias detected. The authors conclude that CNN-based models show strong pooled diagnostic performance, though the small number of studies limits how broadly these results can be applied.
Mitochondrial DNA mutations in oral squamous cell carcinoma: A systematic review and meta-analysis.
Nov 18, 2026
This systematic review and meta-analysis asked how common somatic mitochondrial DNA (mtDNA) mutations are in oral squamous cell carcinoma (OSCC), where their hotspots lie, and whether they have diagnostic or prognostic value. Pooling eight studies (403 patients), the authors estimated a prevalence of 88.1% (95% CI: 69.9-99.1), though heterogeneity was very high (I² = 94.9%). They conclude that mtDNA mutations are highly prevalent in OSCC, but larger, standardised studies are needed to establish their clinical utility.
Salivary inflammatory and matrix remodeling biomarkers in oral submucous fibrosis: A systematic review of diagnostic accuracy.
Nov 18, 2026
This systematic review asked whether salivary inflammatory, fibrotic, matrix-remodeling, signaling, and transcriptomic biomarkers can help diagnose oral submucous fibrosis (OSMF), following PRISMA and PRISMA-DTA guidance across ten included studies. The authors found that MMP-12 (elevated in OSMF) and TGF-β isoforms showed the most promising diagnostic signals, while IL-10, IL-1β, and TNF-α were inconsistent, and EGFR, S100A7, miRNA-21, and transcriptomic panels were preliminary. Because the certainty of evidence is low to very low, the authors conclude these biomarkers may serve only as adjunctive tools and require external validation before clinical use.
Fisetin induces G0/G1 arrest and apoptosis via mTOR signalling in HSC-3 cells.
Nov 18, 2026
Fisetin, a natural flavonoid, is evaluated for its ability to kill and halt the growth of HSC-3 oral carcinoma cells, with a focus on whether it acts through the mTOR signalling pathway. The authors measured dose-dependent cytotoxicity (MTT assay, IC50), changes in mTOR-related gene expression (e.g., 4EBP1, Glut1, PKM2, RAPTOR, S6K1, SGK1) by qRT-PCR, and fisetin's binding to mTOR pathway proteins via molecular docking. They report that fisetin reduces proliferation-associated gene expression, promotes apoptotic gene expression, and binds strongly to mTOR signalling proteins, suggesting it as a candidate for oral cancer therapy pending in vivo and clinical studies.
Comparative evaluation of stromal characteristics in developmental, inflammatory, and neoplastic oral lesions using Masson's Trichrome staining.
Nov 18, 2026
This study compared stromal collagen features in odontogenic keratocysts, radicular cysts, and fibromas using Masson's Trichrome staining across seven semi-quantitative parameters. The authors asked whether collagen characteristics differ among these developmental, inflammatory, and neoplastic lesions. They found significant differences in staining intensity, subepithelial thickness, and collagen maturity, with OKCs showing immature, loosely arranged collagen, radicular cysts showing moderately mature fibres, and fibromas showing dense, mature collagen, suggesting that this low-cost stain may aid routine diagnostic interpretation.
